Effects of Repeated Doses of Intravenous Immunoglobulin in Myasthenia Gravis
- 1 May 1988
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 295 (5) , 438-443
- https://doi.org/10.1097/00000441-198805000-00005
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Adverse Cardiovascular Effects of Anticholinesterase MedicationsThe Lancet Healthy Longevity, 1987
- High-Dose Intravenous Methylprednisolone in Myasthenia GravisArchives of Neurology, 1985
- THE NATURAL COURSE OF MYASTHENIA GRAVIS AND EFFECT OF THERAPEUTIC MEASURESAnnals of the New York Academy of Sciences, 1981
- ASPECTS OF THE NATURAL HISTORY OF MYASTHENIA GRAVIS: CRISIS AND DEATHAnnals of the New York Academy of Sciences, 1981
- CORTICOTROPIN AND CORTICOSTEROIDS IN GENERALIZED MYASTHENIA GRAVIS: COMPARATIVE STUDIES AND ROLE IN MANAGEMENTAnnals of the New York Academy of Sciences, 1976
- Autoimmune Response to Acetylcholine ReceptorScience, 1973
- Corticosteroids in management of severe, generalized myasthenia gravisNeurology, 1972
- Myasthenia GravisArchives of internal medicine (1960), 1961
- Fatalities in Myasthenia GravisNeurology, 1956
- Pharmacology of the anticholinesterase drugs—mestinon, prostigmin, tensilon and TEPPThe American Journal of Medicine, 1955